0 items USD 0.00Search
Your search for "glioblastoma" gave back 58 results.
The global Recurrent Glioblastoma Multiforme Treatment market size was valued at US$ 509 million in 2024 and is forecast to a readjusted size of USD...
颁补迟补濒辞驳:听
GIR
February 2025
Price: USD 3,480.00
The global Recurrent Glioblastoma Multiforme Treatment market size is predicted to grow from US$ 510 million in 2025 to US$ 730 million in 2031; it...
颁补迟补濒辞驳:听
LPI
January 2025
Price: USD 3,660.00
The global Glioblastoma Multiforme Therapeutics market size was valued at US$ 536.3 million in 2023. With growing demand in downstream market, the...
颁补迟补濒辞驳:听
LPI
December 2024
Price: USD 3,660.00
The global Glioblastoma Multiforme Therapeutics market size was valued at USD 564.1 million in 2023 and is forecast to a readjusted size of USD 990.5...
颁补迟补濒辞驳:听
GIR
November 2024
Price: USD 3,480.00
Glioblastoma multiforme (GBM) is a fast-growing type of tumour of the brain or spinal cord. It is the most common type of primary malignant brain...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 3,950.00
The global Glioblastoma Multiforme Treatment (GBM) market size was valued at USD 564.1 million in 2023 and is forecast to a readjusted size of USD...
颁补迟补濒辞驳:听
GIR
July 2024
Price: USD 3,480.00
The global market for Recurrent Glioblastoma Multiforme Treatment was estimated to be worth US$ 463.4 million in 2023 and is forecast to a readjusted...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 3,950.00
The global market for Recurrent Glioblastoma Multiforme Treatment was valued at US$ 495 million in the year 2024 and is projected to reach a revised...
颁补迟补濒辞驳:听
MRRPB5
January 2025
Price: USD 2,900.00
The global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was valued at USD 476.8 million in 2023 and is forecast to a readjusted size...
颁补迟补濒辞驳:听
GIR
July 2024
Price: USD 3,480.00
The global Recurrent Glioblastoma Multiforme Treatment market size was valued at USD 476.8 million in 2023 and is forecast to a readjusted size of...
颁补迟补濒辞驳:听
GIR
June 2024
Price: USD 3,480.00
Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat, and despite all efforts, median overall survival remains at...
颁补迟补濒辞驳:听
LPI
August 2024
Price: USD 3,660.00
The global Glioblastoma Multiforme Treatment (GBM) market size was valued at US$ 536.3 million in 2023. With growing demand in downstream market, the...
颁补迟补濒辞驳:听
LPI
March 2024
Price: USD 3,660.00
The global Glioblastoma Treatment Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030...
颁补迟补濒辞驳:听
GIR
August 2024
Price: USD 3,480.00
The global Glioblastoma Treatment Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Glioblastoma...
颁补迟补濒辞驳:听
LPI
March 2024
Price: USD 3,660.00
The global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was valued at US$ 453.4 million in 2023. With growing demand in downstream...
颁补迟补濒辞驳:听
LPI
March 2024
Price: USD 3,660.00
听
